121 related articles for article (PubMed ID: 25730797)
21. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
22. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
23. Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir.
Snejdrova E; Drastik M; Dittrich M; Kastner P; Nguyenova J
Drug Dev Ind Pharm; 2016 Oct; 42(10):1653-9. PubMed ID: 26925606
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.
Schädlich A; Kempe S; Mäder K
J Control Release; 2014 Apr; 179():52-62. PubMed ID: 24503251
[TBL] [Abstract][Full Text] [Related]
25. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
Tang Y; Singh J
Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202
[TBL] [Abstract][Full Text] [Related]
26. The effect of polymer composition on the gelation behavior of PLGA-g-PEG biodegradable thermoreversible gels.
Tarasevich BJ; Gutowska A; Li XS; Jeong BM
J Biomed Mater Res A; 2009 Apr; 89(1):248-54. PubMed ID: 18464255
[TBL] [Abstract][Full Text] [Related]
27. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
[TBL] [Abstract][Full Text] [Related]
28. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.
Liang R; Zhang R; Li X; Wang A; Chen D; Sun K; Liu W; Li Y
Eur J Pharm Sci; 2013 Nov; 50(3-4):502-10. PubMed ID: 23994054
[TBL] [Abstract][Full Text] [Related]
29. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system.
Meng ZX; Xu XX; Zheng W; Zhou HM; Li L; Zheng YF; Lou X
Colloids Surf B Biointerfaces; 2011 May; 84(1):97-102. PubMed ID: 21227661
[TBL] [Abstract][Full Text] [Related]
31. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
[TBL] [Abstract][Full Text] [Related]
32. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
33. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
Saxena V; Sadoqi M; Shao J
Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
[TBL] [Abstract][Full Text] [Related]
34. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
Cho KY; Lee S; Park JK
Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system.
Hu C; Feng H; Zhu C
Colloids Surf B Biointerfaces; 2012 Jun; 95():162-9. PubMed ID: 22424828
[TBL] [Abstract][Full Text] [Related]
37. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
Clark A; Milbrandt TA; Hilt JZ; Puleo DA
Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
[TBL] [Abstract][Full Text] [Related]
38. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
[TBL] [Abstract][Full Text] [Related]
40. The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.
Li J; Rothstein SN; Little SR; Edenborn HM; Meyer TY
J Am Chem Soc; 2012 Oct; 134(39):16352-9. PubMed ID: 22950719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
